Edition:
United Kingdom

Express Scripts Holding Co (ESRX.OQ)

ESRX.OQ on NASDAQ Stock Exchange Global Select Market

87.39USD
17 Aug 2018
Change (% chg)

-- (--)
Prev Close
$87.39
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,138,269
52-wk High
$87.68
52-wk Low
$55.80

Chart for

About

Express Scripts Holding Company is a pharmacy benefit management (PBM) company. The Company is engaged in providing healthcare management and administration services to its clients, including managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers' compensation... (more)

Overall

Beta: 0.88
Market Cap(Mil.): $36,015.96
Shares Outstanding(Mil.): 577.55
Dividend: --
Yield (%): --

Financials

  ESRX.OQ Industry Sector
P/E (TTM): 10.82 20.98 40.76
EPS (TTM): 5.76 -- --
ROI: 10.77 11.71 62.30
ROE: 22.51 13.91 73.91

Express Scripts staking out million dollar gene therapies

Express Scripts Holding Co built a multi-billion enterprise pressuring drug companies to lower their prices for U.S. patients. Now it is quietly building a side business: getting paid to help drug companies dispense a new generation of high-priced drugs.

15 Aug 2018

CORRECTED--Express Scripts staking out million dollar gene therapies

Aug 15 Express Scripts Holding Co built a multi-billion enterprise pressuring drug companies to lower their prices for U.S. patients. Now it is quietly building a side business: getting paid to help drug companies dispense a new generation of high-priced drugs.

15 Aug 2018

RPT-FOCUS-Express Scripts staking out million dollar gene therapies

Aug 15 Express Scripts Holding Co built a multi-billion enterprise pressuring drug companies to lower their prices for U.S. patients. Now it is quietly building a side business: getting paid to help drug companies dispense a new generation of high-priced drugs.

15 Aug 2018

Express Scripts staking out million-dollar gene therapies

Express Scripts Holding Co built a multi-billion enterprise pressuring drug companies to lower their prices for U.S. patients. Now it is quietly building a side business: getting paid to help drug companies dispense a new generation of high-priced drugs.

15 Aug 2018

Express Scripts staking out million-dollar gene therapies

Express Scripts Holding Co built a multi-billion enterprise pressuring drug companies to lower their prices for U.S. patients. Now it is quietly building a side business: getting paid to help drug companies dispense a new generation of high-priced drugs.

15 Aug 2018

FOCUS-Express Scripts staking out million dollar gene therapies

Aug 15 Express Scripts Holding Co built a multi-billion enterprise pressuring drug companies to lower their prices for U.S. patients. Now it is quietly building a side business: getting paid to help drug companies dispense a new generation of high-priced drugs.

15 Aug 2018

Icahn reverses position on Cigna-Express Scripts deal

Activist investor Carl Icahn said on Monday that he no longer intended to solicit proxies to vote against the $52 billion Cigna-Express Scripts deal, a turn around from his position last week when he urged the health insurer's shareholders to vote against it.

14 Aug 2018

Icahn reverses position on Cigna-Express Scripts deal

Activist investor Carl Icahn said on Monday that he no longer intended to solicit proxies to vote against the $52 billion Cigna-Express Scripts deal, a turn around from his position last week when he urged the health insurer's shareholders to vote against it.

14 Aug 2018

UPDATE 1-Icahn reverses position on Cigna-Express Scripts deal

Aug 13 Activist investor Carl Icahn said on Monday that he no longer intended to solicit proxies to vote against the $52 billion Cigna-Express Scripts deal, a turn around from his position last week when he urged the health insurer's shareholders to vote against it.

14 Aug 2018

Deals of the day-Mergers and acquisitions

Aug 13 The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Monday:

13 Aug 2018

Competitors

Earnings vs. Estimates